Skip to search formSkip to main contentSkip to account menu

ganstigmine

Known as: (-)-O-((2'-ethylphenyl)carbamoyl)geneseroline hydrochloride, (4AS,9AS)-2,3,4,4a,9,9a-Hexahydro-2,4a,9-Trimethyl-1,2-Oxazino(6,5-B)Indol-6-Yl O-Ethylcarbanilate 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Summary. We have investigated the effect of ganstigmine (CHF2819), a novel geneserine derived acetylcholinesterase (AChE… 
2003
2003
The objective of this study was to evaluate the safety, tolerability, maximum tolerated dose, pharmacokinetics, and… 
2003
2003
In order to deepen the understanding of the metabolism of Ganstigmine, a new acetylcholinesterase inhibitor under evaluation for… 
Review
2003
Review
2003
Ganstigmine (CHF-2819) is being developed by Chiesi as a potential treatment for neurodegenerative and cognitive disorders. The… 
Review
2002
Review
2002
2001
2001
Ganstigmine, a new acetylcholinesterase inhibitor, was incubated with rat liver microsomes and the resulting metabolites were…